INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Using Technology To Reduce Monitoring Costs And Increase Quality
Join industry experts as they discuss how the true value of DDC lies not just in the cost of the technology itself but in the operational efficiencies it unlocks.
-
Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs
Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
-
Meeting 100% Recruitment 7 Months Ahead Of Schedule
Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.
-
Your Benefits To Working With A Clinical Research Marketing Agency
Distinguish your clinical trial through partnering with a clinical research marketing agency to effectively attract and retain eligible participant with customized campaigns and digital marketing.
-
Benefit From Enhanced Power And Intelligence8/14/2025
Find a supply automation value engine with intelligent automation and algorithms to analyze drug supply data and automatically adjust delivery quantities to each site based on data available in IRT.
-
Planning For High-Performance Hematologic Oncology Clinical Trials5/7/2024
Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.
-
Central eSource Is The Latest In Sponsor Provided Site Offerings7/7/2025
For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.
-
Site Engagement Improves Study Support And Results12/10/2025
Dedicated site engagement helps reduce administrative burden, improve participant access, and keep studies moving. This approach strengthens workflows and supports sites throughout every phase.
-
How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs3/17/2025
Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Avance Clinical offers deep scientific expertise and extensive knowledge across a range of specialized therapeutic indications, consistently achieving global regulatory approvals.
-
IQVIA’s Learning Management System (LMS) provides sites and study teams with a single, efficient source for education and learning, knowledge assessments, reporting and more.
-
Learn how a bioanalytical testing partner with comprehensive solutions and unwavering commitment to quality can help you bring safe and effective drugs to market with confidence.
-
PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.
-
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.